Showing results (11-20 of 321) with videos related to
Sort By:
Pageof 33
Cancer Chemotherapy and Pharmacology|January 1, 1987
A comparison of adriamycin and mAMSA. II. Studies with V79 and human tumour multicellular spheroidsC M West, I J StratfordChemico-Biological Interactions|August 1, 1982
The effect of caffeine on the cytotoxicity of misonidazole and some other nitroheterocyclic compoundsM R Horsman, I J StratfordEssays in Biochemistry|January 1, 1997
Role of nitric oxide in growth of solid tumours: a balancing actE C Chinje, I J StratfordInternational Journal of Radiation Oncology, Biology, Physics|August 1, 1986
Chemosensitization by monofunctional alkylating agentsJ M Walling, I J StratfordBiochemical Pharmacology|March 22, 1996
Enzymology of the reduction of the novel fused pyrazine mono-n-oxide bioreductive drug, RB90740 roles for P450 reductase and cytochrome b5 reductaseH M Barham, I J StratfordThe British Journal of Cancer. Supplement|July 1, 1996
The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapyG U Dachs, I J StratfordInternational Journal of Radiation Oncology, Biology, Physics|April 1, 1989
The differential hypoxic cytotoxicity of bioreductive agents determined in vitro by the MTT assayI J Stratford, M A StephensInternational Journal of Radiation Oncology, Biology, Physics|May 15, 1994
Bioreductive drugs for cancer therapy: the search for tumor specificityG E Adams, I J StratfordBritish Journal of Cancer|March 1, 1977
Effect of hyperthermia on differential cytotoxicity of a hypoxic cell radiosensitizer, Ro-07-0582, on mammalian cells in vitroI J Stratford, G E AdamsBritish Journal of Cancer|July 1, 1981
Cytotoxic properties of a 4-nitroimidazole (NSC 38087): a radiosensitizer of hypoxic cells in vitroI J Stratford, C Williamson, C HardyPageof 33